This document presents the Workers Compensation Research Institute's Medical Price Index for Workers' Compensation, Third Edition (MPI-WC). It introduces the MPI-WC, which measures annual price changes for nonhospital medical services covered by workers' compensation insurance. The MPI-WC was developed using claims data to create a "market basket" of typical services, and it tracks prices across states from 2002 to 2010. It analyzes price trends for overall nonhospital services and specific groups like evaluation and management, surgery, and radiology. State-level data and interstate comparisons of price indices in 2010 are also provided.
Role and Scope of MIS in Monitoring and Surveillance Systems of HPNSDPMEASURE Evaluation
Presented by Karar Zunaid Ahsan, MEASURE Evaluation's Sr. Resident M&E Advisor for Bangladesh, at the Global Conference on Community Health in March 2013.
Role and Scope of MIS in Monitoring and Surveillance Systems of HPNSDPMEASURE Evaluation
Presented by Karar Zunaid Ahsan, MEASURE Evaluation's Sr. Resident M&E Advisor for Bangladesh, at the Global Conference on Community Health in March 2013.
New Drug Opportunity Assessments Strat Planning For Future SuccessPharmacision LLC
Pharmaceutical Business Development, Marketing and Strategic Planning Groups need an early read on opportunities, but oftentimes don’t have time or budget for extensive market research.
Pharmacision presents a step by step opportunity assessment and valuation process through a case study format.
Benefits of employing this process:
Quickly weed out projects with very low probability of commercial success,
Construct a framework for deeper dive assessments to validate and refine assumptions when greater market knowledge is needed before making go/no go decisions, Support clinical development and commercialization strategic planning, Reduce overall costs.
Global Uro-Gynecological Surgical Devices IndustryReportLinker.com
This report analyzes the worldwide markets for Uro-Gynecological Surgical Devices in US$ Million by the following segments: Urological Surgical Devices (Sling & Suspension Devices, & Other Urological Devices), and Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, & Other Gynecological Devices). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia'Pacific, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 66 companies including many key and niche players such as Gyrus ACMI Corporation, American Medical Systems Holdings Incorporated, Boston Scientific Corporation, C. R. Bard, Inc., Cook Urological Inc., CooperSurgical, Inc., Hologic Inc., Ethicon, Inc., Cytyc Corporation, Cytyc Surgical Products, Ethicon Inc., Karl Storz GmbH & Co. KG, MDMI Technologies, Inc., Medtronic, Inc., Olympus America Inc., Olympus Surgical & Industrial America, Inc., Richard Wolf GmbH, and Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
10-Year Orthopedics and Spine Forecast: Factors Impacting DemandWellbe
What’s in store for the next 10 years of orthopedics and spine service lines?
Kristi Crowe, Associate Vice President and Orthopedic service line leader at Sg2 will review future demand for orthopedics and spine services nationally, key factors impacting this demand, and opportunities to build your access channels and differentiate your orthopedics and spine services to capture growth.
About the Speaker:
As a member of Sg2’s Center for Strategic Planning, Kristi Crowe leads Sg2’s intelligence and analytics in orthopedics and works with leadership teams to improve growth and performance across the care continuum. She also leads the development of orthopedics service line–oriented publications and educational offerings and speaks nationally at a variety of physician and health care leadership conferences.
With 18 years of clinical, management, and consulting health care experience, Kristi brings a variety of strategic skills to Sg2, which have included physician alignment strategies, volume growth initiatives, and performance enhancement for orthopedic services.
Before joining Sg2, Kristi worked in orthopedic service line consulting for Accelero Health Partners, a fully owned subsidiary of Zimmer. While at Accelero, Kristi established and executed strategic plans for the musculoskeletal service line and led the organization’s internal spine and outcomes development initiatives. Working as the liaison between hospital administration and physicians, Kristi facilitated completion of higher level physician engagement strategies such as comanagement agreements. Earlier in her career, Kristi worked as a physical therapist in inpatient, outpatient and management positions.
She graduated summa cum laude with bachelor’s and master’s degrees in physical therapy from the University of North Dakota.
She is a member of the Healthcare Financial Management Association and American Society for Quality, and maintains her Colorado license to practice physical therapy.
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
This presentation addresses the need for a proactive approach to physician recruiting, increasing a hospital's market awareness & reducing the amount of revenue lost when physicians refer their patients to another hospital.
This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 101 companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, Applera Corporation, Celera, Biom
Quality Staffing & Performance: Ensuring Quality and Safety While Managing Co...Best Practices
This study provides insights into how medical device companies are mobilizing resources to support meeting quality standards and regulations throughout the product life cycle. This research establishes meaningful metrics around Quality cost and staffing as well as organizational structure for the function in the U.S. and globally.
Regenerative Medicines: Bone and Joint ApplicationsReportLinker.com
Provides a comprehensive overview of the global market for regenerative medicines for bone and joint applicationsOffers the background for demographics underlying the market for bone and joint productsContains global market forecasts for regenerative medicines for bone and joint applications, with trends and forecasts for growth through 2014Describes the leading bone and joint diseases and disorders using regenerative technologies, including incidence and current methods of treatmentDiscusses regulatory issues affecting regenerative medicine productsProfiles leading and emerging companies.
New Drug Opportunity Assessments Strat Planning For Future SuccessPharmacision LLC
Pharmaceutical Business Development, Marketing and Strategic Planning Groups need an early read on opportunities, but oftentimes don’t have time or budget for extensive market research.
Pharmacision presents a step by step opportunity assessment and valuation process through a case study format.
Benefits of employing this process:
Quickly weed out projects with very low probability of commercial success,
Construct a framework for deeper dive assessments to validate and refine assumptions when greater market knowledge is needed before making go/no go decisions, Support clinical development and commercialization strategic planning, Reduce overall costs.
Global Uro-Gynecological Surgical Devices IndustryReportLinker.com
This report analyzes the worldwide markets for Uro-Gynecological Surgical Devices in US$ Million by the following segments: Urological Surgical Devices (Sling & Suspension Devices, & Other Urological Devices), and Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, & Other Gynecological Devices). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia'Pacific, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 66 companies including many key and niche players such as Gyrus ACMI Corporation, American Medical Systems Holdings Incorporated, Boston Scientific Corporation, C. R. Bard, Inc., Cook Urological Inc., CooperSurgical, Inc., Hologic Inc., Ethicon, Inc., Cytyc Corporation, Cytyc Surgical Products, Ethicon Inc., Karl Storz GmbH & Co. KG, MDMI Technologies, Inc., Medtronic, Inc., Olympus America Inc., Olympus Surgical & Industrial America, Inc., Richard Wolf GmbH, and Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
10-Year Orthopedics and Spine Forecast: Factors Impacting DemandWellbe
What’s in store for the next 10 years of orthopedics and spine service lines?
Kristi Crowe, Associate Vice President and Orthopedic service line leader at Sg2 will review future demand for orthopedics and spine services nationally, key factors impacting this demand, and opportunities to build your access channels and differentiate your orthopedics and spine services to capture growth.
About the Speaker:
As a member of Sg2’s Center for Strategic Planning, Kristi Crowe leads Sg2’s intelligence and analytics in orthopedics and works with leadership teams to improve growth and performance across the care continuum. She also leads the development of orthopedics service line–oriented publications and educational offerings and speaks nationally at a variety of physician and health care leadership conferences.
With 18 years of clinical, management, and consulting health care experience, Kristi brings a variety of strategic skills to Sg2, which have included physician alignment strategies, volume growth initiatives, and performance enhancement for orthopedic services.
Before joining Sg2, Kristi worked in orthopedic service line consulting for Accelero Health Partners, a fully owned subsidiary of Zimmer. While at Accelero, Kristi established and executed strategic plans for the musculoskeletal service line and led the organization’s internal spine and outcomes development initiatives. Working as the liaison between hospital administration and physicians, Kristi facilitated completion of higher level physician engagement strategies such as comanagement agreements. Earlier in her career, Kristi worked as a physical therapist in inpatient, outpatient and management positions.
She graduated summa cum laude with bachelor’s and master’s degrees in physical therapy from the University of North Dakota.
She is a member of the Healthcare Financial Management Association and American Society for Quality, and maintains her Colorado license to practice physical therapy.
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
This presentation addresses the need for a proactive approach to physician recruiting, increasing a hospital's market awareness & reducing the amount of revenue lost when physicians refer their patients to another hospital.
This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 101 companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, Applera Corporation, Celera, Biom
Quality Staffing & Performance: Ensuring Quality and Safety While Managing Co...Best Practices
This study provides insights into how medical device companies are mobilizing resources to support meeting quality standards and regulations throughout the product life cycle. This research establishes meaningful metrics around Quality cost and staffing as well as organizational structure for the function in the U.S. and globally.
Regenerative Medicines: Bone and Joint ApplicationsReportLinker.com
Provides a comprehensive overview of the global market for regenerative medicines for bone and joint applicationsOffers the background for demographics underlying the market for bone and joint productsContains global market forecasts for regenerative medicines for bone and joint applications, with trends and forecasts for growth through 2014Describes the leading bone and joint diseases and disorders using regenerative technologies, including incidence and current methods of treatmentDiscusses regulatory issues affecting regenerative medicine productsProfiles leading and emerging companies.